CCL5 Deficiency Aggravates Acute DSS-Induced Colitis by Restricting IL-33-Induced Formation of Tregs in Intestinal Tract

Resarchers investigate chemokine ligand 5 (CCL5) as a critical immune modulator in Ulceralive Colitis, focusing on its effects on immune cell activation, particularly regulatory T cell formation, and the molecular pathways involved in these processes.